Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
  • A23L2/52—Adding ingredients
  • A23L2/54—Mixing with gases
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/28—Compounds containing heavy metals
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
  • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
  • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/22—Peroxides; Oxygen; Ozone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
  • A61K2800/22—Gas releasing

Definitions

• the invention relates to a method of generating prophylactic means for treating the human body and mind, for example drugs, but also nutrients and cosmetics, which have an improved quality.
• gaseous elements which can be used are hydrogen, oxygen, nitrogen, fluorine, chlorine and the noble gases helium, neon, argon, krypton, xenon and radon.
• the Bunsen absorption coefficient ⁇ of dissolved carbon dioxide (CO 2 ) per ml of solvent at a temperature of 37°C and an air pressure of 760mm Hg is 0,51 ml.
• oxygen (O 2 ) in the same situation the absorption coefficient ⁇ is 0.024 ml.
• the CO 2 solubility in plasma is thus about twenty times higher than the O 2 solubility.
• the solubility of atmospheric nitrogen in water at 20°C and 1 bar amounts to 23.54 ml/1 and of nitrogen 18.6 ml/1.
• gases present in atmospheric air have a particular biological and environmentally significant character with a potency-enhancing effect. Accordingly such gaseous elements, that is, gases obtained from atmospheric air but also manufactured gases, have an important nourishing and health- giving significance as well as biological and technological significance.
• gases obtained from atmospheric air but also manufactured gases have an important nourishing and health- giving significance as well as biological and technological significance.
• argon the noble gas present in atmospheric air in a volume percentage of 0.93, has an anti-proliferative action which is of particular significance in the prevention and treatment of neoplasms.
• Carbon dioxide (CO 2 ) as an end product of the substrate breakdown takes part in the build-up and breakdown reactions of the human body and is of great significance for the human organism and our environment. Without carbon dioxide the formation of energy-rich nutrients by photosynthesis in plants is impossible.
• gases such as argon (Ar), oxygen (O ), ozone (O 3 ), nitrogen (N 2 ) and carbon dioxide (CO ).
• the therapeutic effect can be reinforced in particular in medicine as monotherapy or in combination with other therapeutic methods such as hyperthermy and/or ionising, photonising measures as well as combinations of minerals and trace elements, vitamins, chemo- and radiotherapy introduced into the medical treatment.
• cancer cells can also be sensitised before chemo- and radio-therapy by some gases such as oxygen and ozone and thereby can be better attacked and countered.
• the invention is based on solving the problem of producing suitable means for the treatment of the human body, such as drugs, but also nutrients and cosmetics, in physiological and body-friendly form in a biological better quality. Thereby in particular new and effective healing means can be developed in the medical field.
• I provide a process for producing enhanced means for treating the human body, for example drugs, nutrients and cosmetics, the means comprising components, and the process comprising enriching at least one of the components by the use of one or more physiological and harmless gaseous elements, either present in the atmosphere or manufactured, to enhance the potency of the means for treating the human body.
• the means for treatment of the body are increased in potency and effectiveness in that they contain one or more harmless gas with a concentration above the natural gas saturation level.
• the enriching may be performed at, above or below atmospheric pressure. It may be performed at above or below room temperature, but preferably not less than 0°C.
• the gaseous elements may be supplied in chemically pure form, or in conjunction with other chemical elements.
• Oxygen may be supplied by carbon dioxide or hydrogen peroxide.
• the potency-enhancing action proposed according to the invention for drugs, but also nutrients as well as cosmetics, using gases has the aim of delivering the biologically and bio-energetically effective forces of the gases employed in the feeding and healing process of the body as well as in the field of cosmetics and thereby of achieving positive biological effects in this field.
• the potency-enhancing and function-raising of drugs, especially sera, blood and substances being similar to blood with gases or with other elements and/or substances in combination is herein further described.
• potency-enhancing and function-raising of drugs, nutrients and cosmetics by gases in a high-molecular, ionised or atomic form takes place amongst other things by mixing, addition, enrichment or in a liposome form.
• the ratio of the gas concentration is different with different drugs, nutrients or cosmetics.
• the gas concentration increases to increase the potency- enhancement or enrichment with gases.
• Haemaccel a blood substitute
• Haemaccel has an O concentration of 8 mg/1 before enrichment with oxygen at 18°C and 760 mm Hg air pressure.
• the O concentration under the otherwise identical conditions is increased to at least 42 mg/1.
• the process according to the present invention further provides a method for the potency-enhancing and function-raising of drugs, especially sera, blood and substances being similar to blood with gases as a mono-therapy or a combination therapy with other elements and/or substances in combination for infusion, transfusion and for usage as special nutrients.
• the process and the substances according to the present invention also apply to infusions into the blood track and the lymph track.
• Haemaccel 35 has the following composition, in that 1000 ml of Haemaccel contains:
• Polypeptide cross-linked with urea links 35g (corresponding to 6.3g»N)
• Electrolyte content in mmol/1 Na + 145, K + 5/1, Ca ++ 6.25, Cl " 145.
• volume deficiency shock blood and plasma loss, filling of heart-lung machines, carrier solution for various medicaments.
• the new medicament produced after potency-enhancement with oxygen acts amongst other things significantly more effectively and rapidly in the treatment of shock and for volume substitution.
• further indication fields are, amongst things, heart ailments, micro-circulation failures as well as failures in the field of CNS and finally cancers.
• Another example in this connection is natural blood.
• blood like many medicaments and healing materials, is enhanced in potency with gases, amongst them oxygen, ozone and the like, and introduced in therapy with a high degree of effectiveness.
• gases amongst them oxygen, ozone and the like
• blood is made up chiefly of water, fat, carbohydrates, protein, oxygen, carbonic acids, phosphoric acids, sulphuric acids, blood plasma, blood platelets, minerals, amino acids, hormones, enzymes, etc.
• Blood which has had its potency enhanced in accordance with the invention has a special status in clinical-scientific medicine and a broad spectrum in prophylaxis, therapy and imrnuno-stimulation.
• the indications for blood preparations with enhanced potency in accordance with the invention by gases, in particular oxygen, include the treatment of shock, major surgery, in particular in trauma medicine, transplant surgery, heart and neuro surgery as well as in conservative therapy fields such as anaemia and hypoxy, microcirculation failure, immunostimulation and cancer and Aids.
• potency-enhancement of a drug is sodium selenite- pentahydrate having the chemical formula Na 2 SeO *5 H 2 O which has a positive and broad prophylactic and therapy spectrum.
• the oxygen concentration in sodium selenite-pentahydrate is increased and thereby its positive therapeutic effect as a drug is increased.
• the potency-enhanced solution of sodium selenite-pentahydrate in a 0.9% NaCl solution (saline) was successfully prescribed enterally and/or parenterally as an infusion, amongst other things in selenium deficiency, as antioxidant and antitoxic, in complaints of the heart, vascular diseases, complaints of the lungs, liver, pancreas and eyes as well as in brain tumour patients and as an immuno stimulant and anti-carcinogen.
• Carbon dioxide (CO 2 ) is also of particular medical and nutritional significance. Potency-enhancement of water with CO 2 alters the taste of the water. It tastes sourer. Furthermore CO 2 has a hyperemic effect in particular for the cell part of the meninges (pia mater).
• drugs nutrients and cosmetics can be enhanced in potency using carbon dioxide.
• the therapeutic effect of medicinal carbon dioxide (CO ) is shown by subcutaneous CO 2 injection.
• the indications for CO 2 include cervical, shoulder, arm and lumbal syndromes, neck and head pains as well as peripheral arterial circulation complaints.
• Local CO 2 gas insufflation provides an improved circulation and local hyperemisation.
• liquids with argon atomic number 18 and relative atomic mass 39948
• Liquids, such as water, enriched with argon have health-giving effects and can be used for the treatment of illnesses such as cancer.
• Helium air (a mixture of oxygen and helium gas) can likewise be employed for the purpose of enriching liquids. Furthermore helium gas is used for prophylaxis against bends. Helium air is likewise used in the treatment of bronchial asthma.
• the following tables show examples of potency-enhancing, dynamising and enrichment of drugs, nutrients and cosmetics with gases.
• a Proportionality factor (shows how many cc of a gas are dissolved in one cc liquid under standard condition i.e. at a partial pressure of 101
• Kpa 760 mrnHg and at a temperature of 0°C
• Potency-enhanced and gas-enriched drugs can be used and prescribed orally or parenterally, namely as rectal, intravenous, intraarterial, intracavity, such as intracardial, intrapericardial, intrapleural, intravesical and intraperitoneal prescription. This use has potentially positive wide-ranging preventive, therapeutic, rehabilitative and regulatory effects.
• the invention enables drugs enriched or with their potency enhanced with a gas, and nutrients and/or cosmetics, to be produced.
• the human body can be supplied with physiologically enhancing, regenerating, immuno-stimulating, anti-oxidative, anti-toxic, anti-bacterial, anti-proliferative and anti-carcinogenic materials.
• the molecular structure of the potency-enhanced drugs, but also nutrients and cosmetics, produced in accordance with the invention is of such a form that they act as physiological and harmless media in the human body.
• drugs nutrients or cosmetics can have their potency enhanced at any desired concentrations of gases and introduced in prophylaxis and therapy in the treatment of illnesses.
• the prophylactic and therapeutic effectiveness are increased, amongst them the anti-tumour effect of these drugs in brain tumour patients.
• oxygen fluid infusion therapy OFIT
• OSIT oxygen sera infusion therapy
• the means according to the invention also have a regulatory action on the sympathetic nerve system and para-sympathetic nerve system as well as on the chemo-receptors in the glomus caroticum with a blood-pressure regulating effect.
• drugs of enhanced potency can be prescribed as an infusion or injection isotonic or hypertonic common salt solutions, electrolytes, amino acids, glucose solutions, Haemaccel and the like with oxygen (O 2 ), nitrogen (N 2 ), ozone, (O 3 ), argon (Ar), krypton (Kr), carbon dioxide (CO 2 ) in different degrees of saturation with positive therapeutic effects.
• These drugs with potency enhanced with gases can be introduced in the treatment of various illnesses such as heart and lung complaints, cancers, Aids and illnesses of the central nervous system, intrathoracic and intraabdominal, urological, gynaecological, gastrointestinal, eye and ENT complaints as well as in transplant surgery, aerospace medicine and for dialysis patients.
• PCGIT potency-enhanced combined gas infusion therapy
• a further interesting aspect of the present invention is its use in treating headaches.
• Patients with headaches, including migraines and stress headaches exhibited a significant therapeutic benefit after treatment with water of which the potency had been enhanced by oxygen.
• Immuno- stimulation and modulation form important aspects in the use of media produced in accordance with the present invention.
• oral and parenteral prescription of drugs and nutrients having their potency enhanced with gases the immune system in the cellular and humoral field is stimulated and modulated.
• Cancer and Aids therapy likewise form important fields of use of drugs with their potency enhanced with gas, the drugs being used by infusion therapy.
• This therapy is used successfully in the two stated fields, which are chiefly associated with immunity defects.
• physiological common salt solutions having their potency enhanced with oxygen used as an infusion in cancer patients, result in the cancer cells being damaged and sensitised and better attacked than with chemo and radiotherapy.
• the chemotherapy itself is surprisingly improved when the drugs are dissolved in such physiological common salt solutions.
• a further particular aspect of the drugs of enhanced potency produced in accordance with the present invention is the multi-factor prophylactic and therapeutic effect.
• these drugs can be used in conservation medicine, for example as a prophylactic measure in cerebral and cardiac hypoxy, in complaints of the lungs, liver, kidneys and pancreas as well as in cases of anaemia and circulation problems.
• the potency- enhanced media can be prescribed in the cleansing of wounds or skin complaints, orally, rectally as well as intraperitoneally, intravesically, intrapleurally and intrabronchially in collapsed lungs and acute lung failure.
• These media are, as well as other therapeutic measures, pharmaco-therapeutically competent and can be successfully introduced in the acute therapy phase or in the immediate measures in treating shock, assisting circulation as well as on heart failure and in resuscitation.
• the oxygen partial pressure (pO 2 ) in the human body is increased.
• a further aspect of the enhancement of the potency of drugs and nutrients is the optimisation of the material interchange and energy generation of the cells with enhancement and stimulation of the biological and bio-energetic bodily processes, which are generally desirable for health and are of particular significance for sportsmen and sports women.
• Particularly important aspects of the present invention are the prophylactic and therapeutic possibilities on illnesses of vital organs such as brain, heart and vascular system, lungs, liver, kidneys, pancreas, skin, eyes, ears and the immune system.
• vital organs such as brain, heart and vascular system, lungs, liver, kidneys, pancreas, skin, eyes, ears and the immune system.
• the circulation to the human brain is set at 55 to 56 ml per minute per 100 g of brain tissue. These values are about twice as high in young children and are significantly lower in older people.
• the human brain takes about 20% of the oxygen consumption of the human body.
• An interruption of the flow of blood to the cerebrum for five seconds causes dizziness as a first signal and a few seconds later unconsciousness.
• Tissue and organ complaints as a consequence of interruptions in the circulation and reductions in the functioning of tissues, in particular brain tissues, by hypoxy, microcirculation failure, Alzheimer's and even brain tumours can be treated prophylactically and also after occurrence using drugs having enhanced potency through gases in accordance with the invention.
• drugs having enhanced potency through gases in accordance with the invention.
• older people in particular can be assisted and a premature damage to the functioning of the brain can be prevented.
• a particularly important and significant aspect of the present invention lies in fighting effectively against infections originating from anaerobic exciting agents, which are amongst the most frequent infections acquired in hospital.
• Anaerobic exciting agents reside chiefly on the skin, in the mouth, digestive tract, in particular in the colon and in the vagina and occur alone or as mixed infections.
• the mouth and pharynx regions belong, amongst others, to the most frequently attacked regions for the residence of anaerobic exciting agents, which originate through infections such as tooth or gum abscesses, parodontoses, gingivitis and Ludwig's angina.
• anaerobic infections arise such as sinusitis, otitis media, otogenic meningitis, brain abscesses, lung abscesses, aspiration pneumonia, pleuraempyema, peritonitis, intra-abdominal and perirectal abscesses as well as wound infections.
• the first condition for the growth requirement of anaerobes is an oxygen deficit or a low oxygen pressure. Accordingly the aim is to fight effectively against anaerobic infections by administration of oxygen or pharmaceuticals and nutrients, as well as cosmetics, enriched with oxygen and/or with ozone.
• a particularly significant feature of this invention is that infections originating from anaerobic exciting agents are countered by the administration of nutrients and pharmaceuticals, as well as cosmetics, enriched and made more potent with oxygen and/or ozone, by external or internal application.
• An important aspect of the invention with particular significance in the health service relates to the use of pharmaceuticals and nutrients, as well as: cosmetics, enriched and made more potent using a gas or gases, as a monotherapy or in combination with other means in the fight against infections with anaerobic exciting agents.
• disinfectants for example as disinfectants, wound-cleansing agents, compresses and bathing means as well as in intracavital installations and cleansing of the infected body cavities, such as pleuraempyema, peritonitis, adnexitis, cystitis, sinusitis and similar illnesses.
• the infections originating from anaerobic exciting agents generate a purulent and unpleasant smell.
• mouth and/or breath odours which represent a physical and social burden for those affected.
• a further field of use for water enriched with oxygen or ozone lies in dental treatment, in particular in the operative and conservation field.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• General Health & Medical Sciences (AREA)
• Epidemiology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Engineering & Computer Science (AREA)
• Nutrition Science (AREA)
• Food Science & Technology (AREA)
• Polymers & Plastics (AREA)
• Mycology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Dermatology (AREA)
• Emergency Medicine (AREA)
• Inorganic Chemistry (AREA)
• Birds (AREA)
• Organic Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Alternative & Traditional Medicine (AREA)
• Hematology (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=7878141

Family Applications (1)

Country Status (2)

Cited By (3)

Families Citing this family (1)

Citations (5)

• 1998
  • 1998-08-20 DE DE19837790A patent/DE19837790A1/de not_active Withdrawn
• 1999
  • 1999-08-14 WO PCT/EP1999/005981 patent/WO2000010576A1/de not_active Ceased

Patent Citations (5)

Also Published As

Similar Documents

Legal Events